Renata Maria de Noronha

Renata Maria de Noronha

Auto-generated profile, based on publicly available information

Renata Maria de Noronha

Faculdade de Ciências Médicas da Santa Casa de São Paulo, Departamento de Pediatria, Ambulatório de Diabetes Pediátrico, São Paulo, SP, Brasil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2019 in Jornal de Pediatria
Verified
Journal Article
Open access
LCLuis Eduardo Calliari
Luis Eduardo Calliari
FAFlavia Jacqueline Almeida
Flavia Jacqueline Almeida
RNRenata Maria Noronha
Renata Maria Noronha
The association between diabetes mellitus and infections is very common. These infections, even when mild, interfere with blood glucose control. The aim of this review is to describe infections that occur in children and adolescents with DM, as well as to provide recommendations on glycemia management during these episodes. A non-systematic review was carried out in the PubMed database, using the terms "diabetes mellitus," "infection," "children," and "adolescents." The most relevant publications were selected. In addition to the usual community diseases, some infections may occur predominantly in diabetic patients, especially when there is inadequate glycemic control, and common infections can be more severe in these patients. Alterations caused by the disease itself and the immune response are responsible for the risk of higher frequency and severity of infections. During infections, an increase in blood glucose occurs and usually an increase in insulin dose is required. Pediatric patients with diabetes have some immune system disorders that, when associated with high glycemia, increase the risk of infections and their severity, and should be promptly identified and treated. The presence of an infectious condition, in turn, raises blood glucose and increases the risk of decompensation, and pediatricians should be cautioned to intensify monitoring and insulin therapy, and to avoid the risk of DKA. It should also be noted that many infections are preventable and can be avoided with adequate vaccine coverage.

25 May 2022 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
ALArthur Lyra
Arthur Lyra
FFFernanda Rodrigues Ferreira
Fernanda Rodrigues Ferreira
RMRegina Célia Santiago Moisés
Regina Célia Santiago Moisés
RNRenata Maria de Noronha
Renata Maria de Noronha
LCLuis Eduardo Calliari
Luis Eduardo Calliari
SUMMARY Neonatal diabetes mellitus (NDM) is a monogenic form of diabetes occurring mainly in the first 6 months of life. Approximately 30% of transient NDM (TNDM) cases will have an activating mutation in the KATP channel genes ABCC8 and KCNJ11. The majority of the patients with KCNJ11 mutations who are receiving insulin treatment can be transferred to treatment with sulfonylurea (SU), with an improvement in metabolic control and quality of life. Intermittent continuous glucose monitoring (iCGM) is used to assess [...] SUMMARY Neonatal diabetes mellitus (NDM) is a monogenic form of diabetes occurring mainly in the first 6 months of life. Approximately 30% of transient NDM (TNDM) cases will have an activating mutation in the KATP channel genes ABCC8 and KCNJ11. The majority of the patients with KCNJ11 mutations who are receiving insulin treatment can be transferred to treatment with sulfonylurea (SU), with an improvement in metabolic control and quality of life. Intermittent continuous glucose monitoring (iCGM) is used to assess

29 April 2021 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
DPDébora Martins Ferreira Pessoa
Débora Martins Ferreira Pessoa
NONara Lívia Rezende Soares da Paz Oliveira
Nara Lívia Rezende Soares da Paz Oliveira
GDGiuliane de Santana Dantas
Giuliane de Santana Dantas
VFVania de Fátima Tonetto Fernandes
Vania de Fátima Tonetto Fernandes
RNRenata Maria de Noronha
Renata Maria de Noronha
LCLuis Eduardo Calliari
Luis Eduardo Calliari
Objective: People with Down's syndrome (DS) have a higher risk of developing type 1 diabetes mellitus (T1D) and may have specific clinical features compared to T1D patients without DS. This study evaluated the clinical and laboratory aspects of T1D in children and adolescents with DS in an admixed population. Subjects and methods: A case-control study comparing patients with T1D and DS (T1D+DS) to patients with T1D without DS (T1D controls) from two tertiary academic Hospitals in Sao Paulo, Brazil. Results: The sample consisted of 9 patients with T1D+DS and 18 T1D age and sex -matched controls. Anti-glutamic acid decarboxylase 65 antibodies were positive in 7/7 of the 9 T1D+DS patients, confirming the presence of diabetes autoimmunity in this group. Mean age at diagnosis of T1D was 4.9 +/- 3.9 years in the T1D+DS group and 6.4 years +/- 3 in the T1D control group; early diagnosis (<2 years old) occurred in three T1D+DS patients but only in one T1D control patients, both suggesting lower age of diagnosis in T1D+DS group, although without statistical significance (p = 0.282 and p = 0.093, respectively). The T1D+DS group presented lower total insulin dose (0.7 I11/kg/day +/- 0.2) and HbA1c (7.2% +/- 0.6) than the control group (1.0 I11/kg/day +/- 0.3 and 9.1% +/- 0.7, respectively) (p = 0.022 and p = 0.047, respectively). Conclusion: We confirmed the autoimmune etiology of diabetes in people with DS in this admixed population. T1D+DS patients developed diabetes earlier and achieved better metabolic control with a lower insulin dose than T1D controls. These findings are in agreement with previous studies in Caucasian populations. Arch Endocrinol Metab. 2021;65(5):562-9

18 March 2020 in Jornal de Pediatria (Versão em Português)
Verified
Journal Article
Open access
PDF file
LCLuis Eduardo Calliari
Luis Eduardo Calliari
FAFlavia Jacqueline Almeida
Flavia Jacqueline Almeida
RNRenata Maria Noronha
Renata Maria Noronha
The association between diabetes mellitus and infections is very common. These infections, even when mild, interfere with blood glucose control. The aim of this review is to describe infections that occur in children and adolescents with DM, as well as to provide recommendations on glycemia management during these episodes. A non‐systematic review was carried out in the PubMed database, using the terms “diabetes mellitus,” “infection,” “children,” and “adolescents.” The most relevant publications were selected. In addition to the usual community diseases, some infections may occur predominantly in diabetic patients, especially when there is inadequate glycemic control, and common infections can be more severe in these patients. Alterations caused by the disease itself and the immune response are responsible for the risk of higher frequency and severity of infections. During infections, an increase in blood glucose occurs and usually an increase in insulin dose is required. Pediatric patients with diabetes have some immune system disorders that, when associated with high glycemia, increase the risk of infections and their severity, and should be promptly identified and treated. The presence of an infectious condition, in turn, raises blood glucose and increases the risk of decompensation, and pediatricians should be cautioned to intensify monitoring and insulin therapy, and to avoid the risk of DKA. It should also be noted that many infections are preventable and can be avoided with adequate vaccine coverage. A associação entre diabetes mellitus e infecções é muito frequente. Essas infecções, mesmo quando leves, interferem no controle da glicemia. O objetivo desta revisão é descrever as infecções que ocorrem em crianças e adolescentes com DM, bem como orientar o manejo glicêmico nestes episódios. Foi feita uma revisão não sistemática na base de dados PubMed, com os termos “diabetes mellitus”, “infecção”, “crianças” e “adolescentes”. Foram selecionadas as publicações mais relevantes. Além de infecções comunitárias habituais, algumas infecções ocorrem predominantemente no paciente com diabetes, principalmente quando não há um controle glicêmico adequado, e infecções comuns podem ser mais graves nesse paciente. Alterações da própria doença e da resposta imune, em conjunto com alterações do microbioma, são responsáveis pela maior frequência e gravidade das infecções. Durante as infecções, ocorre um aumento da glicemia e habitualmente é necessário o aumento da dose de insulina. O paciente pediátrico com diabetes apresenta algumas desordens imunes que, quando associadas a elevaçao da glicemia, aumentam o risco de infecção e sua gravidade. A presença da infecção, por sua vez, eleva a glicemia e aumenta o risco de descompensação. Desta forma, a monitorização da glicemia, bem como o aumento da dose de insulina, são fundamentais para evitar o risco de cetoacidose diabética. Destaca‐se ainda que muitas infecções são imunopreveníveis e podem ser evitadas com uma cobertura vacinal adequada.